ARWR
Price
$15.95
Change
+$0.29 (+1.85%)
Updated
Jun 26, 04:46 PM (EDT)
Capitalization
2.16B
46 days until earnings call
BEAM
Price
$17.17
Change
+$0.41 (+2.45%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
1.69B
47 days until earnings call
Interact to see
Advertisement

ARWR vs BEAM

Header iconARWR vs BEAM Comparison
Open Charts ARWR vs BEAMBanner chart's image
Arrowhead Pharmaceuticals
Price$15.95
Change+$0.29 (+1.85%)
Volume$1.07K
Capitalization2.16B
Beam Therapeutics
Price$17.17
Change+$0.41 (+2.45%)
Volume$42.85K
Capitalization1.69B
ARWR vs BEAM Comparison Chart in %
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. BEAM commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Buy and BEAM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ARWR: $15.66 vs. BEAM: $16.76)
Brand notoriety: ARWR: Notable vs. BEAM: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 56% vs. BEAM: 81%
Market capitalization -- ARWR: $2.16B vs. BEAM: $1.69B
ARWR [@Biotechnology] is valued at $2.16B. BEAM’s [@Biotechnology] market capitalization is $1.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARWR and BEAM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 3 TA indicator(s) are bullish while BEAM’s TA Score has 3 bullish TA indicator(s).

  • ARWR’s TA Score: 3 bullish, 4 bearish.
  • BEAM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ARWR is a better buy in the short-term than BEAM.

Price Growth

ARWR (@Biotechnology) experienced а +0.26% price change this week, while BEAM (@Biotechnology) price change was -1.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.94%. For the same industry, the average monthly price growth was +32.55%, and the average quarterly price growth was +15.14%.

Reported Earning Dates

ARWR is expected to report earnings on Aug 11, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.16B) has a higher market cap than BEAM($1.69B). ARWR YTD gains are higher at: -16.702 vs. BEAM (-32.419). ARWR has higher annual earnings (EBITDA): -68.12M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. ARWR (1.1B). BEAM has less debt than ARWR: BEAM (158M) vs ARWR (388M). ARWR has higher revenues than BEAM: ARWR (545M) vs BEAM (63.6M).
ARWRBEAMARWR / BEAM
Capitalization2.16B1.69B128%
EBITDA-68.12M-399.03M17%
Gain YTD-16.702-32.41952%
P/E RatioN/AN/A-
Revenue545M63.6M857%
Total Cash1.1B1.22B90%
Total Debt388M158M246%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRBEAM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTEQX15.020.06
+0.40%
Templeton Emerging Markets Small Cap R6
MFECX129.97N/A
N/A
MFS Growth C
JDURX15.49N/A
N/A
PGIM Jennison Utility R
AGCLX19.49N/A
N/A
American Century Global Small Cap A
OAKWX24.87-0.06
-0.24%
Oakmark Global Select Investor